Cannabis MSOs Continue To Plummet: Down 7% This Week

green plant on blue plastic pot

Image Source: Unsplash

The 12 largest multi-state operators (MSOs), as tracked in the munKNEE American Cannabis MSOs Index, are ranked below, in descending order, as to:

their stock performances week-ending March 25th, 2023 with
their likelihood of Financial Distress within the next 2 years (according to data from macroaxis.com), and
their average 12-month Price Targets (from SeekingAlpha.com),
their extent of Short Interest (from SeekingAlpha.com), and
their Insider Ownership (from SeekingAlpha.com).

Declines of Less Than 5%:

Verano (VRNOF):
- 13 analysts:
- have an average 12-month price target of $12.50
  - representing a 330% increase from the March 24th price of $2.91 and
- have a consensus Strong Buy rating.
- In addition, VRNOF has:
  - a 64% chance of Financial Distress within 2 years,
  - a NIL Short Interest; and
  - only 2.1% Insider Ownership.
- Read: Verano Q3 Financial Report Reveals Major Increase In Net Loss
  - Verano: A Top Cannabis Pick For 2023
TerrAscend (TRSSF):
- 11 analysts:
- have an average 12-month price target of $2.40
  - representing a 66% increase from the March 24th price of $1.45 and
- have a consensus Buy rating.
- In addition, TRSSF has:
  - a 64% chance of Financial Distress within 2 years,
  - a NIL Short Interest; and
  - only 6.6% Insider Ownership.
- Read: TerrAscend Q3 Financial Report Reveals Major Declines In Income And EBITDA
  - TerrAscend Hopes The USA Can Provide A Future It Controls
Green Thumb (GTBIF):
- 21 analysts:
- have an average 12-month price target of $19.19
  - representing a 144% increase from the March 24th price of $7.85 and
- have a consensus Strong Buy rating.
- In addition, GTBIF has:
  - a 10% chance of Financial Distress within 2 years,
  - a NIL Short Interest; and
  - a 14.3% Insider Ownership.
- Read: Green Thumb Reports Record Revenue And Adjusted Operating EBITDA
  - Green Thumb Industries: Best Of Breed In U.S. Cannabis

Declines Between 5% and 10%

Trulieve (TCNNF):
- 19 analysts:
- have an average 12-month price target of $18.33
  - representing a 220% increase from the March 24th price of $5.73 and
- have a consensus Strong Buy rating.
- In addition, TCNNF has:
  - a 69% chance of Financial Distress within 2 years,
  - a NIL Short Interest; and
  - 18.7% Insider Ownership.
- Read: Trulieve Q4 Financials: Revenue Static; Net Loss Reduced By 33%
Planet 13 (PLNHF):
- 3 analysts:
- have an average 12-month price target of $0.95
  - representing a 22% increase from the March 24th price of $0.78 and
- have a consensus Buy rating.
- In addition, PLNHF has:
  - a 46% chance of Financial Distress within 2 years,
  - a NIL Short Interest; and
  - 38.8% Insider Ownership.
- Read: Planet 13 Financial Metrics In Q3 All Declined
  - Planet 13 Is Down But Not Out In The Cannabis Industry
Cresco Labs (CRLBF):
- 12 analysts:
- have an average 12-month price target of $5.50
  - representing a 262% increase from the March 24th price of $1.52 and
- have a consensus Buy rating.
- In addition, CRLBF has:
  - a 76% chance of Financial Distress within 2 years,
  - a NIL Short Interest; and
  - a 22.1% Insider Ownership.
- Read: Cresco Labs Q3 Financials Show No Improvement Over Q2 Results
  - - Cresco Labs: An Unloved U.S. Cannabis Multi-State Operator

Declines Between 10% and 15%

Columbia Care (CCHWF):
- 2 analysts:
- have an average 12-month price target of $5.12
  - representing a 904% increase from the March 24th price of $0.51 and
- have a consensus Strong Buy rating.
- In addition, CCHWF has:
  - a 72% chance of Financial Distress within 2 years,
  - a NIL Short Interest; and
  - 17.9% Insider Ownership.
- Read: Columbia Care Reports Third Quarter 2022 Results
  - Cannabis Company Columbia Care Is A Bargain
Jushi (JUSHF):
- 4 analysts:
- have an average 12-month price target of $3.14
  - representing a 516% increase from the March 24th price of $0.51 and
- have a consensus Buy rating.
- In addition, JUSHF has:
  - a 71% chance of Financial Distress within 2 years,
  - a 1.32% Short Interest; and
  - only a 8.9% Insider Ownership.
- Read: Jushi Holdings Releases Mixed Preliminary Q3 Financials
  - Jushi Holdings: Still Trading At A Distressed Valuation
Ascend (AAWH):
- 2 analysts:
  - have an average 12-month price target of $2.88
    - representing a 172% increase from the March 24th price of $1.06 and
  - have a consensus Moderate Buy rating.
  - In addition, AAWH has:
    - a 74% chance of Financial Distress within 2 years,
    - a NIL Short Interest (the number of shorted shares divided by the number of shares outstanding); and
    - only 5.5% Insider Ownership (directors and senior officers or other beneficial holders with 10% or more of the common shares).
  - Read: Ascend Wellness Q3 Report: Record Revenue, Adjusted Gross Profit, And EBITDA Margin
Curaleaf (CURLF):
- 20 analysts:
- have an average 12-month price target of $9.63
  - representing a 228% increase from the March 24th price of $2.94 and
- have a consensus Strong Buy rating.
- In addition, CURLF has:
  - a 39% chance of Financial Distress within 2 years,
  - a NIL Short Interest; and
  - 38.9% Insider Ownership.
- Read: Curaleaf Q3 Report Reveals 80% Decrease In Net Profit
  - Curaleaf: Former Leader In U.S. Cannabis Remains Buyable
Ayr (AYRWF):
- 11 analysts:
- have an average 12-month price target of $4.19
  - representing a 535% increase from the March 24th price of $0.66 and
- have a consensus Strong Buy rating.
- In addition, AYRWF has:
  - a NIL Short Interest; and
  - only a 8.0% Insider Ownership.
- Read: Ayr Wellness Q4 Financials: Operating Loss Increases; EBITDA Improves
Acreage (ACRDF/ACRHF):
- 2 analysts:
- have an average 12-month price target of $ (N/A)
  - representing a (N/A)% increase from the March 24th price of $1.17 and
- have a consensus Hold rating.
- In addition, Acreage has:
  - a 80% chance of Financial Distress within 2 years,
  - a NIL Short Interest; and
  - a 11.9% Insider Ownership.
- Read: Acreage Reports Third Quarter 2022 Financial Results
  - Cresco Labs, Columbia Care M&A deal closure extended to June